Hilltop Holdings Inc. Bristol Myers Squibb CO Transaction History

Hilltop Holdings Inc.

  • $1.53 Billion
  • Q3 2024

A detailed history of Hilltop Holdings Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hilltop Holdings Inc. holds 37,416 shares of BMY stock, worth $2.16 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
37,416
Previous 31,429 19.05%
Holding current value
$2.16 Million
Previous $1.31 Million 48.35%
% of portfolio
0.13%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $237,444 - $309,827
5,987 Added 19.05%
37,416 $1.94 Million
Q2 2024

Aug 14, 2024
BUY
$40.25 - $52.99 $313,708 - $413,004
7,794 Added 32.98%
31,429 $1.31 Million
Q1 2024

May 15, 2024
BUY
$47.98 - $54.4 $42,654 - $48,361
889 Added 3.91%
23,635 $1.28 Million
Q4 2023

Feb 09, 2024
SELL
$48.48 - $57.85 $486,593 - $580,640
-10,037 Reduced 30.62%
22,746 $1.17 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $114,332 - $127,841
1,975 Added 6.41%
32,783 $1.9 Million
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $485,342 - $538,897
7,618 Added 32.85%
30,808 $1.97 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $59,993 - $68,045
913 Added 4.1%
23,190 $1.61 Million
Q4 2022

Feb 14, 2023
SELL
$68.48 - $81.09 $32,528 - $38,517
-475 Reduced 2.09%
22,277 $1.6 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $1,823 - $1.08 Million
-14,027 Reduced 38.14%
22,752 $1.62 Million
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $122,655 - $135,086
1,689 Added 4.81%
36,779 $2.83 Million
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $610,373 - $731,892
-9,928 Reduced 22.05%
35,090 $2.56 Million
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $31,534 - $36,761
588 Added 1.32%
45,018 $2.81 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $150,114 - $175,839
2,537 Added 6.06%
44,430 $2.63 Million
Q2 2021

Aug 16, 2021
BUY
$61.91 - $67.42 $575,329 - $626,534
9,293 Added 28.51%
41,893 $2.8 Million
Q1 2021

May 17, 2021
BUY
$59.34 - $66.74 $758,483 - $853,070
12,782 Added 64.5%
32,600 $2.06 Million
Q4 2020

Feb 16, 2021
SELL
$57.74 - $65.43 $107,454 - $121,765
-1,861 Reduced 8.58%
19,818 $1.23 Million
Q3 2020

Nov 16, 2020
BUY
$57.43 - $63.64 $324,134 - $359,184
5,644 Added 35.2%
21,679 $1.31 Million
Q2 2020

Aug 14, 2020
SELL
$54.82 - $64.09 $23,134 - $27,045
-422 Reduced 2.56%
16,035 $943,000
Q1 2020

May 15, 2020
BUY
$46.4 - $67.43 $81,339 - $118,204
1,753 Added 11.92%
16,457 $918,000
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $95,664 - $124,785
1,944 Added 15.24%
14,704 $944,000
Q3 2019

Nov 14, 2019
BUY
$42.77 - $50.71 $159,189 - $188,742
3,722 Added 41.18%
12,760 $647,000
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $320,103 - $353,965
-7,174 Reduced 44.25%
9,038 $410,000
Q1 2019

May 15, 2019
BUY
$45.12 - $53.8 $391,235 - $466,499
8,671 Added 114.98%
16,212 $774,000
Q4 2018

Feb 14, 2019
SELL
$48.76 - $63.23 $64,021 - $83,020
-1,313 Reduced 14.83%
7,541 $392,000
Q3 2018

Nov 14, 2018
SELL
$55.19 - $62.25 $67,497 - $76,131
-1,223 Reduced 12.14%
8,854 $550,000
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $80,696 - $100,579
-1,597 Reduced 13.68%
10,077 $557,000
Q1 2018

May 15, 2018
SELL
$59.92 - $68.98 $971,243 - $1.12 Million
-16,209 Reduced 58.13%
11,674 $739,000
Q4 2017

Feb 14, 2018
BUY
$59.94 - $65.35 $199,540 - $217,550
3,329 Added 13.56%
27,883 $1.71 Million
Q3 2017

Nov 14, 2017
BUY
$55.23 - $63.74 $1.36 Million - $1.57 Million
24,554
24,554 $1.57 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hilltop Holdings Inc. Portfolio

Follow Hilltop Holdings Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Holdings Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email